| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |